Health Care

In many ways, U.S. health care is the envy of the world—it has helped many individuals live longer than ever and enjoy a better quality of life than previously possible. However, we continue to face the challenge of making quality health care more affordable, more accessible, and more reliable for all Americans. 

The Chamber is focused on promoting effective private sector solutions to our health care challenges that will help control costs, expand access, and improve the quality of care.

Projects and Programs

 

 


Our Priorities

 

Priorities

Access and Affordability
  • Suspend/repeal the Affordable Care Act (ACA) taxes that raise costs for employers and consumers, including the health insurance tax, the medical device tax, and the Cadillac tax.
  • Enable greater flexibility for businesses as they offer health care coverage voluntarily to their employees.
  • Support the expansion of Association Health Plans.
  • Adopt policies to stabilize the individual market.
Wellness, Innovation, and Value
  • Facilitate and promote workplace wellness programs.
  • Allow health care providers access to information about a patient’s history of substance use disorder to enable better treatment.
  • Oppose the introduction of price controls and rationing into the American health care system.
  • Oppose the adoption of a single-payer, government-run health care system.
  • Support reforms that lead to more value-based, quality-focused, coordinated care.

Recent Activity

Letters to CongressJun 10, 2019 - 10:30am

U.S. Chamber Letter Supporting S. 684, Middle Class Health Benefits Tax Repeal Act of 2019

This letter was sent to the United States Senate, supporting S. 684, the “Middle Class Health Benefits Tax Repeal Act of 2019.”

CommentJun 03, 2019 - 12:00pm

Comments to CMS in response to Proposed Rule on Interoperability and Patient Access

This letter was submitted to the Centers for Medicare and Medicaid Services (CMS) in response to the Proposed Rule, which is intended to move the health care ecosystem in the direction of interoperability, and to improve the access to and quality of information that Americans need to make informed health care decisions.

Above the FoldMay 20, 2019 - 5:15pm
Health insurance form and stethoscope

End Surprise Billing in Healthcare, but Do It Carefully

Here's a solution that protects the patient while addressing the underlying payment dispute without litigation.

Letters to CongressMay 20, 2019 - 12:00pm

U.S. Chamber Letter Supporting the Hatch-Waxman Integrity Act and the CREATES Act

This letter was sent to Senators Thom Tillis and Patrick Leahy, and Representatives Bill Flores and David Cicilline, supporting the Hatch-Waxman Integrity Act and the CREATES Act.

ReportMay 09, 2019 - 10:30am

GPE May Quarterly Update

Global Policy Engagement Quarterly Update for May 2019

Above the FoldApr 30, 2019 - 9:15am
health

Medicare for All Builds a Risky Contraption on a Cracking Foundation

Policymakers should fix the foundation first, before pondering additional risky reforms.

Above the FoldApr 29, 2019 - 9:00am
A stethoscope on American currency

AHPs Are Key to Valuable Health Coverage

At the U.S. Chamber, we believe in removing barriers that stand between Americans and affordable health coverage.

EventApr 29, 2019 - 8:30am to 2:00pm

Innovations: Redesigning Wellness

The U.S. Chamber’s annual wellness event will highlight cutting-edge workplace and community initiatives, with a focus on holistic health, the importance of immunization, and how technology is reshaping benefit design. The event will also address the linkage between health and performance in the workplace.

Letters to CongressApr 12, 2019 - 12:15pm

U.S. Chamber Letter Supporting a Repeal of the Medical Device Tax

This letter was sent to the U.S. House of Representatives supporting H.R. 2207, a bill to repeal the tax on medical devices.

Letters to CongressApr 09, 2019 - 3:45pm

U.S. Chamber Opposing S. 61, “Safe and Affordable Drugs from Canada Act of 2019”

This letter was sent to the United States Senate, opposing S. 61, the “Safe and Affordable Drugs from Canada Act of 2019.”